Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-13

Clinical Trial Update: Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating blood levels and safety of olaparib in patients with advanced solid tumours and varying liver function (completed; results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olaparib (Olaparib)

Snippet

Sponsor: AstraZeneca | Conditions: Solid Tumours | Phase 1 | Status: COMPLETED | Results posted: 2019-09-13